Bottleneck limitations for microRNA-based therapeutics from bench to the bedside

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.70, Iss.3, 2015-03, pp. : 147-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular NO: from bench to bedside

By Tsikas Dimitrios  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 3-3

Springer Publishing Company

Access to resources Recommend Favorite

CETUXIMAB: From Bench to Bedside

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-01 ,pp. : 80-95

Bentham Science Publishers

Access to resources Recommend Favorite

The Multidomain Mobility Lab in Older Persons: From Bench to Bedside. The Assessment of Body Composition in Older Persons at Risk of Mobility Limitations

By  

Current Pharmaceutical Design, Vol. 20, Iss. 19, 2014-05 ,pp. : 3245-3255

Bentham Science Publishers

Access to resources Recommend Favorite

Bullous Pemphigoid: From Bench to Bedside

By Walsh Scott R.A.  

Drugs, Vol. 65, Iss. 7, 2005-01 ,pp. : 905-926

Adis International

Access to resources Recommend Favorite

Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 838-846

Bentham Science Publishers

Access to resources Recommend Favorite